News Archive

UAlbany Researchers Develop New Laser Technique to Test mRNA-Based Therapeutics
Their method relies on Raman spectroscopy, a non-destructive laser technique that analyzes the chemical composition of materials.

Graduate Pathway for Scholars Program Welcomes 2026 Cohort
Early-career STEM researchers shared their work as part of the Graduate Pathway for Scholars program at a presentation and awards ceremony held last week. The growing program aims to encourage students who receive their PhDs in STEM fields at UAlbany to return as faculty members later in their careers.
Study: Crosstalk Inside Cells Helps Pathogens Evade Drugs
New UAlbany research shows that tiny mobile structures inside pathogens "collaborate" in previously unknown ways; in so doing, the broader cell learns how to evade drugs designed to kill it. The work advances our understanding of antibiotic resistance and could someday inform the development of new treatments against disaeases like listeriosis.

Engineering, Life Sciences Lead R&D Growth at UAlbany
UAlbany’s nearly $472M in 2024 R&D more than doubled the number the University reported in the NSF Higher Education Research and Development survey in 2023, driven largely by the return of the Department of Nanoscale Science & Engineering and its semiconductor industry R&D partnerships at the NY Creates Albany NanoTech Complex.

Dozens of UAlbany Researchers Among World’s Top 2% of Scientists
The annual Stanford University report, published through Elsevier, creates a public database of top-cited researchers.

Professor Thomas Begley Awarded Williams-Raycheff Endowed Professorship
UAlbany Distinguished Professor and Associate Director of the RNA Institute Thomas Begley has been honored with Williams-Raycheff Endowed Professorship, recognizing his pioneering work on RNA biology, big data analysis and his leadership in training the next generation of RNA researchers.

Gov. Hochul Announces $50M Life Sciences Expansion for RNA Institute research
The Life Sciences Research Building, which is home to cutting-edge labs where researchers from the RNA Institute blend bench science with AI to help accelerate the development of RNA-based treatments for deadly diseases, will expand by 20,000 s.f.

UAlbany Spinoff Secures New Funding in Bid to Transform Biotechnology
UAlbany’s Professor Scott Tenenbaum, CEO of UAlbany spinoff company sxRNA Technologies, Inc., brought in over $625,000 in new awards to the company in 2025. With the help of this new funding, the company is positioned to advance their technology for applications in medical research, pharmaceutical production and the development of new precision therapeutics.